🚨 #Tweetorial alert🚨- brought to you by @kireports.bsky.social @theisn.org #NephTwitter Not all preeclampsia (PE) is the same. New data on isolated PE vs. PE-HELLP syndrome—and why close monitoring matters for patients' cardiovascular and kidney health www.kireports.org/article/S246...

One of the aged old questions, what do you do about persistent hematuria? This post may answer that! @elbaonelida.bsky.social

@kireports.bsky.social · 3w ago

1/ 🚨Tweetorial Alert🚨 Hey #NephSky! Welcome to a 🆕 #skeetorial brought to you by @KIReports @ISNkidneycare. Please also check out www.kireportscommunity.org educational #blogposts. FOLLOW US!

Learn more about how donor and recipient diabetic status impact kidney graft function! Great job @manoleaandreea.bsky.social

@kireports.bsky.social · 4w ago

1/ Hey #NephTwitter! Welcome to a 🆕 #tweetorial #xtorial brought to you by @KIReports

It is officially March 1, and you know what that means!! #NephMadness! @nephmadness.bsky.social Learn more here: ajkdblog.org/2026/03/01/w...

a man is smiling and saying it 's madness

ALT: a man is smiling and saying it 's madness

media.tenor.com

Can’t wait for this discussion. Already have a few patients on it and have been going well! #NephJC

Nephrology Journal Club@nephjc.bsky.social · 9mo ago

⏰2 hours until #NephJC chat Join us today to learn more about the recently released VALIANT study, which investigates the use of Pegcetacoplan in C3 glomerulonephropathy and immune complex mediated glomerulonephritis

New phase 3 data from the ATTAIN-MAINTAIN trial. #NephSky #Obesity #GLP1 lilly.mediaroom.com/2025-12-18-L...

The future of nephrology

@kireports.bsky.social · 10mo ago

2/🚨Our topic🚨A Comprehensive Framework for Kidney Function Assessment: Summary of the NIDDKD Reimagining Kidney Function Assessment Workshop 👉 www.kireports.org/article/S246... @pbjornstad.bsky.social @danafuhrman.bsky.social @jaykoyner.bsky.social @waikarss.bsky.social @isnkidneycare.bsky.social

Appreciate this excellent work showing GLP-1 agonists reduce mortality in patients on dialysis and improve their chances of receiving a transplant. Hopefully, it will help me get them approved for my patients through the VA. #nephsky journals.lww.com/cjasn/pages/...

Congenital and infantile nephrotic syndrome: genotype-phenotype associations pubmed.ncbi.nlm.nih.gov/41339767/

Thrilled to have our review article on complement-mediated biomarkers published #NephSky journals.lww.com/cjasn/abstra...

Excited to match two amazing nephrology fellows for next year! @childrenscolo.bsky.social

More evidence showing that GLP1s may be modulate rheumatic disease #MedSky #NephSky: rheumatology.org/press-releas... and pubmed.ncbi.nlm.nih.gov/40994310/

Glucagon-Like Peptide-1 Receptor Agonist Use and the Risk of Adverse Cardiac and Kidney Outcomes Among Patients with Systemic Lupus Erythematosus and Lupus Nephritis - PubMed

We found lower risks of adverse CV and kidney outcomes and mortality with GLP-1RA use compared with DPP4i use among patients with lupus and T2D.

pubmed.ncbi.nlm.nih.gov

More tools for our advanced CKD patients!

@kireports.bsky.social · 11mo ago

🧵 New #Skeetorial Drop! 🧵 1/ Hey #NephSky! 👋 We’re back with a fresh #Skeetorial from @kireports.bsky.social , this time diving into: Dapagliflozin in Stage 4 CKD: no diabetes required? 🤔 Let’s unpack what this trial means for your next CKD patient. 💊💭

Late breakers that included children: ✅Setanaxib in Alport (12+) Late breakers that did NOT include children: 🚫Atacicept in IgAN 🚫CONFIDENCE 🚫PISCES: Fish oil in Dialysis 🚫LIBERATE-D 🚫balcinrenone + dapa 🚫Obintuzumab in lupus nephritis 🚫Sibeprenlimab in IgA 🚫MIL62 in membranous +more #KidneyWk

🎨Beautiful visual abstract by Dr Natalia Nombera @roxnonna23.bsky.social #NephJC www.nephjc.com/news/...

Great read on ways of measuring renal function. Shout out to @elbaonelida.bsky.social www.kireportscommunity.org/post/towards...

Towards new ways of assessing kidney function. Where to look to improve?

Written by Elba MedinaReviewed by Brian Rifkin;Sophia AmbrusoToday, current methods for measuring kidney function, due to several critical limitations, need to be reimagined. In the reimagining Kidney...

kireportscommunity.org

A great read on the history and upcoming anticoagulation targets especially for our dialysis patients! #NephSky www.kireportscommunity.org/post/bleedin...

Bleeding, Clotting, and Kidney Disease in Atrial Fibrillation: Can Factor XI Inhibitors Change the Game?

Explore how we are uncoupling hemostasis and thrombosis via Factor XI inhibitors and how it is may change anticoagulation for atrial fibrillation in kidney disease

kireportscommunity.org

Looks like tirzepatide have benefits for those with T1DM, with insulin needs reduced within 2 weeks of treatment. #NephSky #MedSky www.medscape.com/viewarticle/...

First Randomized Trial of Tirzepatide in T1D Shows Benefits

Tirzepatide reduced weight, A1c, and insulin dose in type 1 diabetes in a small randomized controlled trial.

medscape.com

Change is in the Autumn air 🌬️🍂 Join use only on #Bluesky on 9/16/25 at 9pm EST. We're discussing the 2025 ACC/AHA Hypertension Guideline Update. 🫀🫘🧠 #NephSky #MedSky www.nephjc.com/news/accaha2025-klno3

PREVENT, Detect, Treat: What’s New in the 2025 Hypertension Toolkit — NephJC

This week, we will discuss the AHA/ACC 2025 hypertension guideline update. Wow, have eight years flown by?

nephjc.com

There’s continued growing evidence that childhood onset hypertension leads to worse outcomes.

JAMA@jama.com · last yr.

In a large sample of US children born between 1959 and 1966, higher #BloodPressure at age 7 years was associated with greater risk of premature #cardiovascular disease mortality. ja.ma/4meFZCO

Thoughts about Wegovy vs Zepbound for MACE Reduction? #MedSky #NephSky Finding: -Semaglutide showed 29% reduction in MACE Limits: -Small # of events -Retrospective Implications: -Wegovy may be better for those with ASCVD -Does GIP have any CV benefits? sciencehub.novonordisk.com/content/dam/...

Check out the latest @kireports.bsky.social community blog from @husamjz.bsky.social Anticoagulantion in ESRD patients with atrial fibrillation: www.kireportscommunity.org/post/bleeding-clotting-and-kidney-disease-in-atrial-fibrillation-can-factor-xi-inhibitors-change-the-g

Bleeding, Clotting, and Kidney Disease in Atrial Fibrillation: Can Factor XI Inhibitors Change the Game?

By. Husam Alzayer, MD, MSc, MRCPIReviewed by Sophia Ambruso, DOIntroduction Bleeding and thrombosis represent one of the many paradoxes faced by patients with kidney disease. As kidney function declin...

kireportscommunity.org

🤔 How often is end-stage kidney disease in patients with MCD/ FSGS? #NephSky #MedSky @brianrifkin.bsky.social dissected the conclusions from the RaDar study in this #NephJCshorts *the original article from @asnpublications.bsky.social www.nephjc.com/news/nephjc-...

NephJC Shorts: MCD and FSGS Outcomes — NephJC

A NephJC Shorts discussion of the long term data on kidney failure in FSGS and MCD

nephjc.com

Check out the ACHIEVE visual abstract by @nephromommy-akshu.bsky.social www.nephjc.com/news/2025/8/...

The ACHIEVE visual abstract — NephJC

the use of spironolactone in patients on dialysis did not alter mortality or hospitalizations for heart failure. Similar results were seen in the simultaneously released ALCHEMY trial.

nephjc.com

Please share this #Skytorial with your followers and friends! Don't forget to check out KI Reports Community for more: kireportscommunity.org. Thanks to @sophia-kidney.bsky.social, @brianrifkin.bsky.social, and @mchanmd.bsky.social for great feedback!

Bought a construction truck food mat for my 4.5 year old. Instead of letting the food particles stay there he pushes it to the floor to keep the mat clean. “ChildPerspectives

For all my little beans out there, don’t forget to read the latest recommendations on IgAN and IgAVN by @mdabdulqader83.bsky.social on @kireports.bsky.social www.kireportscommunity.org/post/navigat...

Navigating the Challenges of IgA Nephropathy and IgA Vasculitis Nephritis in Children

Written by: Henny Adriani PuspitasariIntroduction:IgA nephropathy (IgAN) and IgA vasculitis nephritis (IgAVN) are kidney diseases that can significantly impact children's health. While they share some...

kireportscommunity.org

💥Hey #NephSky! Welcome to a 🆕 #tweetorial #xtorial brought to you by @KIReports @ISNkidneycare #Skytorial. Our author is @elbaonelida.bsky.social nephrologist at Hospital General de Mexico @hgm_nefrologia. Please also check out www.kireportscommunity.org educational #blogposts. FOLLOW US!🫰

🚨Hey #NephSky! Welcome to a new #Medsky #Skytorial brought to you by @kireports.bsky.social Our author is @brianrifkin.bsky.social nephrologist in Hattiesburg, MS Please check out #KIReportsCommunity educational #blogposts too!

⏰2 hours to chat It’s #NephJC time! Tonight we dive into something BIG —literally & figuratively: the first-ever @kdigo.org 2025 ADPKD guidelines 🧬 Finally, this disease gets its own spotlight. #NephJC

KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) - PubMed

KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

pubmed.ncbi.nlm.nih.gov